// App-Quantinova.ai

3523 : A benefit-harm and cost-effectiveness analysis

Researchers

Presenter

  • Thomas Callender

Principal Investigators

  • Mark Emberton

  • Steve Morris

  • Paul Pharoah

  • Nora Pashayan

Medical Centers

  • Kings College London, London, United Kingdom

  • University of Cambridge, Cambridge, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved